New Stock Just IPO'd
Discover why we think our top stock of 2021 could potentially outperform the market

NYSE:USNA - USANA Health Sciences Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $126.00
  • Forecasted Upside: 25.42 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$100.46
▼ -0.17 (-0.17%)
1 month | 3 months | 12 months
Get New USANA Health Sciences Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for USNA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for USNA

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$126.00
▲ +25.42% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for USANA Health Sciences in the last 3 months. The average price target is $126.00, with a high forecast of $126.00 and a low forecast of $126.00. The average price target represents a 25.42% upside from the last price of $100.46.
Streaming Stocks are Surging
Canadian Live Streaming Stock Set To Win In China & Middle East.
Buy
The current consensus among 2 investment analysts is to buy stock in USANA Health Sciences. This rating has held steady since April 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/22/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/20/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/19/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/18/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/16/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/14/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/15/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/14/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/10/2021Roth CapitalBoost Price TargetBuy$107.00 ➝ $126.00Low
i
Rating by D. Bain at Roth Capital
12/17/2020Roth CapitalInitiated CoverageBuy$107.00Low
i
Rating by D. Bain at Roth Capital
5/12/2020Tigress FinancialReiterated RatingBuyLow
i
8/22/2019Jefferies Financial GroupInitiated CoverageHold$65.00Medium
i
7/24/2019Pivotal ResearchReiterated RatingBuyLow
i
7/3/2019Pivotal ResearchReiterated RatingBuy$75.00High
i
7/3/2019SidotiDowngradeBuy ➝ Neutral$70.00High
i
5/1/2019Pivotal ResearchReiterated RatingBuy$105.00High
i
4/16/2019Tigress FinancialInitiated CoverageBuy ➝ BuyLow
i
10/25/2018SidotiUpgradeNeutral ➝ BuyLow
i
10/24/2018Pivotal ResearchUpgradeHold ➝ Buy$135.00High
i
7/25/2018Pivotal ResearchReiterated RatingHold$135.00Medium
i
4/23/2018Pivotal ResearchDowngradeBuy ➝ Hold$95.00High
i
2/7/2018Pivotal ResearchBoost Price TargetBuy$80.00 ➝ $95.00Medium
i
1/24/2018SidotiDowngradeBuy ➝ NeutralMedium
i
10/25/2017Pivotal ResearchBoost Price TargetBuy$70.00 ➝ $80.00N/A
i
7/26/2017Pivotal ResearchLower Price TargetBuy ➝ Buy$75.00 ➝ $70.00High
i
5/3/2017Pivotal ResearchUpgradeHold ➝ Buy$55.00 ➝ $75.00Low
i
5/1/2017Pivotal ResearchReiterated RatingBuy ➝ Hold$75.00 ➝ $55.00Low
i
2/8/2017Pivotal ResearchLower Price TargetBuy$80.00 ➝ $75.00N/A
i
7/28/2016DA DavidsonBoost Price TargetNeutral$135.00 ➝ $150.00N/A
i
(Data available from 4/14/2016 forward)
USANA Health Sciences logo
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Read More

Today's Range

Now: $100.46
$99.92
$100.46

50 Day Range

MA: $98.59
$91.46
$101.39

52 Week Range

Now: $100.46
$65.00
$102.58

Volume

102 shs

Average Volume

117,024 shs

Market Capitalization

$2.07 billion

P/E Ratio

18.60

Dividend Yield

N/A

Beta

0.98

Frequently Asked Questions

What sell-side analysts currently cover shares of USANA Health Sciences?

The following Wall Street research analysts have issued research reports on USANA Health Sciences in the last twelve months: Roth Capital, Tigress Financial, and Zacks Investment Research.
View the latest analyst ratings for USNA.

What is the current price target for USANA Health Sciences?

1 Wall Street analysts have set twelve-month price targets for USANA Health Sciences in the last year. Their average twelve-month price target is $126.00, suggesting a possible upside of 25.6%. Roth Capital has the highest price target set, predicting USNA will reach $126.00 in the next twelve months. Roth Capital has the lowest price target set, forecasting a price of $126.00 for USANA Health Sciences in the next year.
View the latest price targets for USNA.

What is the current consensus analyst rating for USANA Health Sciences?

USANA Health Sciences currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe USNA will outperform the market and that investors should add to their positions of USANA Health Sciences.
View the latest ratings for USNA.

What other companies compete with USANA Health Sciences?

How do I contact USANA Health Sciences' investor relations team?

USANA Health Sciences' physical mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company's listed phone number is 801-954-7100 and its investor relations email address is [email protected] The official website for USANA Health Sciences is www.usana.com.

Breakthrough AI Tech Stock
Advanced breast cancer imaging tools could catapult this stock into the stratosphere.